Gastrix research

  • Ajmera AV, Shastri GS, Gajera MJ, Judge TA. Suboptimal response to ferrous sulfate in iron-deficient patients taking omeprazole. Am J Ther. 2012;19(3):185-189.
  • Attwood SE, Ell C, Galmiche JP, Fiocca R, et al. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther. 2015 Apr 10. doi: 10.1111/apt.13194.
  • Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 1999;19:357-377.
  • Carmel R. Cobalamin, the stomach, and aging. Am J Clin Nutr. 1997;66(4):750-759.
  • Dharmarajan TS, Kanagala MR, Murakonda P, Lebelt AS, Norkus EP. Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc. 2008;9(3):162-167. doi: 10.1016/j.jamda.2007.10.004. http://www.ncbi.nlm.nih.gov/pubmed/18294598
  • Fellenius E, Berglindh T, Sachs G, et al. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase. Nature. 1981;290(5802):159-161.
  • Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 1998;115(1):42-
  • Food and Drug Administration. Proton pump inhibitor drugs (PPIs): Drug safety communication. Low magnesium levels can be associated with long-term use. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm245275.htm.  Posted March 2, 2011. Updated February 12, 2014. Accessed March 17, 2014.
  • Forte JG, Lee HC. Gastric adenosine triphosphatases: a review of their possible role in HCl secretion. Gastroenterology. 1977;73(4 Pt 2):921-926.  http://www.ncbi.nlm.nih.gov/pubmed/20386
  • Henry, E., Carswell, A., Wirz, A., Fyffe, V. and McColl, K. (2005) Proton pump inhibitors reduce the bioavailability of dietary Vitamin C. Aliment Pharmacol Ther 22: 539–545
  • Hess MW, Hoenderop JG, Bindels RJ, Drenth JP. Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther. 2012;36(5):405-413. doi: 10.1111/j.1365-2036.2012.05201.x. Epub 2012 Jul 4.
  • http://www.nursing.unboundmedicine.com/nursingcentral/ub/citation/9649457/The_clinical_and_economic_value_of_a_short_course_of_omeprazole_in_patients_with_noncardiac_chest_pain_
  • IMS Institute for Healthcare Informatics. The use of medicines in the United States: Review of 2011. http://www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/IHII_Medicines_in_U.S_Report_2011.pdf.  Published April 2012. Accessed December 18, 2013.
  • Koop H, Bachem MG. Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol. 1992;14(4):288-292.
  • Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435-2442. doi:10.1001/jama.2013.280490.  http://www.ncbi.nlm.nih.gov/pubmed/24327038
  • Mowat, C., Carswell, A., Wirz, A. and McColl, K. (1999) Omeprazole and dietary nitrite independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology 116: 813–822
  • Pandak WM, Arezo S, Everett S, et al. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol. 2002;35(4):307-314.
  • Sarges R, Gallagher A, Chambers TJ, Yeh LA. Inhibition of bone resorption by H+/K(+)-ATPase inhibitors. J Med Chem. 1993;36:2828–2830. [PubMed]
  • Sharma VR, Brannon MA, Carloss EA. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. South Med J. 2004 ;97(9):887-889. http://www.ncbi.nlm.nih.gov/pubmed/15455980
  • Stewart CA, Termanini B, Sutliff VE, et al. Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy. Aliment Pharmacol Ther. 1998;12(1):83-98.
  • Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol. 2004;57(4):422-428.